covid - 19后毛霉菌病:临床病例及文献复习

Q4 Medicine

Klinicheskaia mikrobiologiia i antimikrobnaia khimioterapiia Pub Date : 2021-01-01 DOI:10.36488/cmac.2021.3.255-262

S. Khostelidi, V. A. Zaytsev, E. V. Pelikh, É. Yashina, O.N. Rodionova, T. Bogomolova, Y. Avdeenko, N. Klimko

{"title":"covid - 19后毛霉菌病:临床病例及文献复习","authors":"S. Khostelidi, V. A. Zaytsev, E. V. Pelikh, É. Yashina, O.N. Rodionova, T. Bogomolova, Y. Avdeenko, N. Klimko","doi":"10.36488/cmac.2021.3.255-262","DOIUrl":null,"url":null,"abstract":"Mucormycosis is one of the most aggressive invasive mycoses. The mortality rate of patients with mucormycosis, depending on clinical form and background disease, varies from 30% to 100%. This article provides the first description of mucormycosis in Russia after infection caused by SARS-CoV-2, as well as a review of literature reports on mucormycosis in patients with COVID-19 (as of September 2021).","PeriodicalId":53392,"journal":{"name":"Klinicheskaia mikrobiologiia i antimikrobnaia khimioterapiia","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2021-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"5","resultStr":"{\"title\":\"Mucormycosis following COVID19: clinical case and literature review\",\"authors\":\"S. Khostelidi, V. A. Zaytsev, E. V. Pelikh, É. Yashina, O.N. Rodionova, T. Bogomolova, Y. Avdeenko, N. Klimko\",\"doi\":\"10.36488/cmac.2021.3.255-262\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Mucormycosis is one of the most aggressive invasive mycoses. The mortality rate of patients with mucormycosis, depending on clinical form and background disease, varies from 30% to 100%. This article provides the first description of mucormycosis in Russia after infection caused by SARS-CoV-2, as well as a review of literature reports on mucormycosis in patients with COVID-19 (as of September 2021).\",\"PeriodicalId\":53392,\"journal\":{\"name\":\"Klinicheskaia mikrobiologiia i antimikrobnaia khimioterapiia\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2021-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"5\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Klinicheskaia mikrobiologiia i antimikrobnaia khimioterapiia\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.36488/cmac.2021.3.255-262\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q4\",\"JCRName\":\"Medicine\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Klinicheskaia mikrobiologiia i antimikrobnaia khimioterapiia","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.36488/cmac.2021.3.255-262","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"Medicine","Score":null,"Total":0}

引用次数: 5

摘要

毛霉病是最具侵袭性的真菌病之一。毛霉菌病患者的死亡率取决于临床形式和背景疾病，从30%到100%不等。本文首次介绍了俄罗斯由SARS-CoV-2引起的感染后的毛霉病，并回顾了关于COVID-19患者毛霉病的文献报道(截至2021年9月)。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

查看原文本刊更多论文

Mucormycosis following COVID19: clinical case and literature review

Mucormycosis is one of the most aggressive invasive mycoses. The mortality rate of patients with mucormycosis, depending on clinical form and background disease, varies from 30% to 100%. This article provides the first description of mucormycosis in Russia after infection caused by SARS-CoV-2, as well as a review of literature reports on mucormycosis in patients with COVID-19 (as of September 2021).

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

Klinicheskaia mikrobiologiia i antimikrobnaia khimioterapiia Medicine-Epidemiology

CiteScore

0.90

自引率

0.00%

发文量

审稿时长

8 weeks